🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Canada-wide Implementation of a Virtual Sexual Health and Rehabilitation eClinic (SHAReClinic) for Prostate Cancer Patients and Their Partners

Recruitingn/aAges 18 Years - anyMaleUniversity Health Network, Toronto
NCT06877598 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this observational study is to evaluate the effectiveness of SHAReClinic, a national, virtual Sexual Health and Rehabilitation eClinic designed to support prostate cancer patients and their partners. Specifically, this study aims to assess SHAReClinic's impact on improving sexual function, satisfaction, and relational intimacy after treatment. The primary objective is to evaluate SHAReClinic's effectiveness across participating sites and determine its role in supporting long-term sexual health and well-being. As part of usual care, newly enrolled SHAReClinic patients will receive guided education modules and access to sexual health counselling at key recovery milestones. SHAReClinic seeks to expand access to sexual health care for prostate cancer patients across Canada by providing evidence-based, virtual sexual rehabilitation. Findings from this study will inform best pra

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients who are scheduled for first-line treatment for localized prostate cancer, either through radical prostatectomy (open or robotic) or radiation treatment (brachytherapy, external beam) Alone, or with adjuvant Androgen Deprivation Therapy (ADT) OR * Patients currently undergoing active treatment for prostate cancer OR * Patients who have undergone cancer treatment in the past 6 months * Patients who are hormone and/or chemotherapy-naïve * Patients who have access to a computer or smartphone with internet access * Patients who are 18 years of age or older Exclusion Criteria: * Patients on ADT alone as primary treatment, and/or patients on chemotherapy * Patients who lack English proficiency * Patients on nitrate therapy or have other contra-indications to phosphodiesterase type 5 inhibitors (PDE5i's) * Patients with medical conditions that would preclude safe sexual activity * Patients who have had previous treatment for PCa
💊

What it tests

  • Not listed
📍

Where

10 sites
Vancouver Coastal Health Authority
Vancouver, Canada
Men's Health Clinic Manitoba
Winnipeg, Canada
Royal Victoria Regional Health Centre
Barrie, Canada
Dianne & Irving Kipnes Urology Centre
Edmonton, Canada
Kingston Health Sciences Centre
Kingston, Canada
St. Joseph's Health Care London
London, Canada
Trillium Health Partners
Mississauga, Canada
Grass Family Men's Health Center
Ottawa, Canada

…and 2 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy